Resolving the pharmacological redox-sensitivity of SARS-CoV-2 PLpro in drug repurposing screening enabled identification of the competitive GRL-0617 binding site inhibitor CPI-169

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Biochemistry

Chemistry

Immunology

Molecular Biology

Show all topics

DOI

10.1101/2023.10.11.561987

License

CC-BY

Other Formats

PDF